Samsung is importing one million innovative low dead space (LDS) syringes to support India's Covid vaccination drive. This is part of the company's Covid support programme for the country.

LDS syringes minimise the amount of drug left in the syringes after an injection, reducing vaccine wastage, and thereby enabling 20 per cent more people to get the dose with the same amount of vaccine.

LDS syringes, airlifted from South Korea, have been delivered to Uttar Pradesh – 325,000 each to the district administrations in Lucknow and Noida – while 350,000 LDS syringes will soon be handed over to the Greater Chennai Corporation in Tamil Nadu. These syringes will be deployed at Covid vaccination centres in the districts.

This innovative syringe has been introduced for usage in a few markets including the US to optimise vaccination.

"Now, as our country focusses on vaccinating the population, we are supporting this effort with innovative LDS syringes that will help reduce vaccine wastage and vaccinate more people with the same amount of vaccine," said Partha Ghosh, Vice President and Head, CSR, Samsung India.